These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 2835749)

  • 1. Activation of c-Jun transcription factor by substitution of a charged residue in its N-terminal domain.
    Hoeffler WK; Levinson AD; Bauer EA
    Nucleic Acids Res; 1994 Apr; 22(7):1305-12. PubMed ID: 8165146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression.
    Tsuji Y; Akebi N; Lam TK; Nakabeppu Y; Torti SV; Torti FM
    Mol Cell Biol; 1995 Sep; 15(9):5152-64. PubMed ID: 7651432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Jun- and Fos-related proteins in Drosophila are functionally homologous to enhancer factor AP-1.
    Perkins KK; Dailey GM; Tjian R
    EMBO J; 1988 Dec; 7(13):4265-73. PubMed ID: 3149584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming but not immortalizing oncogenes activate the transcription factor PEA1.
    Wasylyk C; Imler JL; Wasylyk B
    EMBO J; 1988 Aug; 7(8):2475-83. PubMed ID: 3142763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types.
    Wasylyk B; Imler JL; Chatton B; Schatz C; Wasylyk C
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):7952-6. PubMed ID: 2847148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation.
    Pertovaara L; Sistonen L; Bos TJ; Vogt PK; Keski-Oja J; Alitalo K
    Mol Cell Biol; 1989 Mar; 9(3):1255-62. PubMed ID: 2725496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleiotropic derepression of developmentally regulated cellular and viral genes by c-myc protooncogene products in undifferentiated embryonal carcinoma cells.
    Onclercq R; Lavenu A; Cremisi C
    Nucleic Acids Res; 1989 Jan; 17(2):735-53. PubMed ID: 2536923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid and cAMP induction mechanisms are differentially affected by the p85gag-mos oncoprotein.
    Hamilton BJ; DeFranco D
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):597-601. PubMed ID: 2536170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of raf oncogenes activates the PEA1 transcription factor motif.
    Wasylyk C; Wasylyk B; Heidecker G; Huleihel M; Rapp UR
    Mol Cell Biol; 1989 May; 9(5):2247-50. PubMed ID: 2501665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein.
    Nunez AM; Berry M; Imler JL; Chambon P
    EMBO J; 1989 Mar; 8(3):823-9. PubMed ID: 2498085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The state of cellular differentiation determines the activity of the adenovirus E1A enhancer element: evidence for negative regulation of enhancer function.
    Herbst RS; Pelletier M; Boczko EM; Babiss LE
    J Virol; 1990 Jan; 64(1):161-72. PubMed ID: 2136708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of jun and fos genes during differentiation of mouse P19 embryonal carcinoma cells.
    de Groot RP; Schoorlemmer J; van Genesen ST; Kruijer W
    Nucleic Acids Res; 1990 Jun; 18(11):3195-202. PubMed ID: 2113273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression by Jun of the Polyoma-virus enhancer overrides activation in a cell specific manner.
    Schneikert J; Imler JL; Wasylyk B
    Nucleic Acids Res; 1991 Feb; 19(4):783-7. PubMed ID: 1850124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a 91-kilodalton PEA3-binding protein is down-regulated during differentiation of F9 embryonal carcinoma cells.
    Martin ME; Yang XY; Folk WR
    Mol Cell Biol; 1992 May; 12(5):2213-21. PubMed ID: 1569949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine growth induced by kinase type oncogenes in myeloid cells requires AP-1 and NF-M, a myeloid specific, C/EBP-like factor.
    Sterneck E; Müller C; Katz S; Leutz A
    EMBO J; 1992 Jan; 11(1):115-26. PubMed ID: 1346759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. v-jun is a transcriptional activator, but not in all cell-lines.
    Imler JL; Ugarte E; Wasylyk C; Wasylyk B
    Nucleic Acids Res; 1988 Apr; 16(7):3005-12. PubMed ID: 2835749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear protooncogenes c-jun and c-fos as regulators of DNA replication.
    Murakami Y; Satake M; Yamaguchi-Iwai Y; Sakai M; Muramatsu M; Ito Y
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3947-51. PubMed ID: 1850842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene v-jun modulates DNA replication.
    Wasylyk C; Schneikert J; Wasylyk B
    Oncogene; 1990 Jul; 5(7):1055-8. PubMed ID: 2165232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner.
    Angel P; Smeal T; Meek J; Karin M
    New Biol; 1989 Oct; 1(1):35-43. PubMed ID: 2518690
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.